FDA 483 - Somerset Medical Center IRB - September 30, 2016

The FDA inspected Somerset Medical Center IRB in Somerville, NJ, and found significant deficiencies in its operations. The inspection revealed multiple failures related to IRB member conduct, meeting procedures, and record-keeping practices. These issues indicate a systemic lack of adherence to regulatory requirements and the IRB's own written procedures.